Skip to main content
MediWound Ltd. logo

MediWound Ltd. — Investor Relations & Filings

Ticker · MDWD ISIN · IL0011316309 LEI · 549300LJKCS74GRYKF90 US Manufacturing
Filings indexed 370 across all filing types
Latest filing 2024-10-01 Major Shareholding Noti…
Country IL Israel
Listing US MDWD

About MediWound Ltd.

https://www.mediwound.com/

MediWound Ltd. is a fully integrated biopharmaceutical company that develops, manufactures, and commercializes enzymatic therapeutics for non-surgical tissue repair. The company's core technology focuses on next-generation treatments that selectively remove eschar (non-viable tissue) from severe burns and chronic wounds while preserving healthy tissue. This approach is designed to accelerate healing, improve patient outcomes, and lower overall healthcare costs. Its primary commercial product is a topical biologic for the debridement of severe thermal burns. MediWound maintains a research and development pipeline aimed at expanding its enzymatic platform to address additional unmet medical needs in wound care.

Recent filings

Filing Released Lang Actions
SCHEDULE 13G
Major Shareholding Notification
2024-10-01 English
Regulatory Filings 2024
Regulatory Filings
2024-09-10 English
424B3
Capital/Financing Update Classification · 100% confidence The document is a prospectus filed pursuant to Rule 424(b)(3) related to the resale of ordinary shares by selling shareholders. It includes detailed information about the offering, risk factors, use of proceeds, dividend policy, selling shareholders, and other legal and financial disclosures typical of a securities offering document. The presence of terms like 'prospectus,' 'selling shareholders,' 'registration statement,' and 'PIPE Transaction' indicates this is a capital raising or financing related document. It is not an annual report, earnings release, or management discussion, nor is it a regulatory filing or announcement of a report. The document is a detailed offering prospectus related to capital markets activity, specifically a resale offering of shares. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is the full prospectus, not just an announcement or a brief summary.
2024-09-09 English
Regulatory Filings 2024
Regulatory Filings Classification · 100% confidence The document is a letter from MediWound Ltd. to the SEC requesting acceleration of the effective date of a Registration Statement on Form F-3. It references a registration statement filed on August 29, 2024, and requests the effective date to be September 9, 2024. The content is a formal regulatory communication related to securities registration and does not contain financial data, audit information, or report content. It is a regulatory procedural filing related to securities law compliance, not a financial report or announcement of results. The document length is short (1522 characters), and it is clearly a regulatory filing rather than a report or announcement of a report publication. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-09-05 English
Regulatory Filings 2024
Regulatory Filings
2024-09-05 English
F-3
Capital/Financing Update Classification · 95% confidence The document is a Form F-3 registration statement filed with the U.S. Securities and Exchange Commission (SEC) by MediWound Ltd. It is a registration statement under the Securities Act of 1933, used for registering securities for resale by selling shareholders. The text includes details about the offering, selling shareholders, risk factors, use of proceeds, and legal matters. It is not a financial report, earnings release, or management discussion. It is a capital markets filing related to securities registration and resale, which fits the category of Capital/Financing Update (CAP). The document is lengthy (15,000 characters) and contains substantive information about the securities offering and registration, not just an announcement or certification. Therefore, the appropriate classification is CAP with high confidence.
2024-08-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.